CeriBell Inc (CBLL)

Currency in USD
21.18
+0.12(+0.57%)
Closed·
21.180.00(0.00%)
·
Earnings results expected in 15 days
CBLL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.8321.31
52 wk Range
10.8524.33
Key Statistics
Prev. Close
21.06
Open
21.19
Day's Range
20.83-21.31
52 wk Range
10.85-24.33
Volume
168.37K
Average Volume (3m)
296.94K
1-Year Change
38.341%
Book Value / Share
4.19
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CBLL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.57
Upside
+30.18%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

CeriBell Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

CeriBell Inc Earnings Call Summary for Q3/2025

  • Ceribell reported Q3 2025 revenue of $22.6 million, up 31% YoY, marking its 30th consecutive quarter of growth, though posted a net loss of $13.5 million ($0.37/share)
  • Gross margin improved to 88%, up from 87% last year, with the company maintaining a strong cash position of $168.5 million despite ongoing losses
  • Stock closed down 3.35% at $11.34 following the earnings announcement, approaching its 52-week low of $10.01
  • Management provided FY2025 revenue guidance of $87-89 million (33-36% growth) and announced expansion into delirium and stroke detection markets
  • CEO Jane Chao noted Ceribell currently serves approximately 10% of U.S. hospitals providing acute care, with ongoing product development in pediatric and neonatal markets
Last Updated: 2025-11-04, 05:46 p/m
Read Full Transcript

Compare CBLL to Peers and Sector

Metrics to compare
CBLL
Peers
Sector
Relationship
P/E Ratio
−15.0x−3.7x−0.4x
PEG Ratio
−0.26−0.050.00
Price/Book
5.2x2.3x2.6x
Price / LTM Sales
9.0x2.4x3.2x
Upside (Analyst Target)
32.2%46.9%46.2%
Fair Value Upside
Unlock17.5%7.2%Unlock

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 27.57
(+30.18% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
TD Cowen
Buy29.00+36.92%-MaintainApr 15, 2026
Canaccord Genuity
Buy30.00+41.64%29.00MaintainDec 17, 2025
BTIG
Buy30.00+41.64%-MaintainDec 15, 2025
Raymond James
Buy26.00+22.76%19.00MaintainDec 09, 2025
TD Cowen
Buy29.00+36.92%20.00MaintainDec 09, 2025

Earnings

Latest Release
Feb 24, 2026
EPS / Forecast
-0.36 / -0.41
Revenue / Forecast
24.8M / --
EPS Revisions
Last 90 days

CBLL Income Statement

People Also Watch

12.41
CTNM
-0.08%
29.720
NAMS
-5.53%
27.51
MLYS
-3.44%
24.93
ALMS
-4.08%
61.45
TARS
+0.79%

FAQ

What Is the CeriBell (CBLL) Stock Price Today?

The CeriBell stock price today is 21.18 USD.

What Stock Exchange Does CeriBell Trade On?

CeriBell is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for CeriBell?

The stock symbol for CeriBell is "CBLL."

What Is the CeriBell Market Cap?

As of today, CeriBell market cap is 802.14M USD.

What Is CeriBell's Earnings Per Share (TTM)?

The CeriBell EPS (TTM) is -1.46.

When Is the Next CeriBell Earnings Date?

CeriBell will release its next earnings report on May 11, 2026.

From a Technical Analysis Perspective, Is CBLL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has CeriBell Stock Split?

CeriBell has split 0 times.

How Many Employees Does CeriBell Have?

CeriBell has 327 employees.

What is the current trading status of CeriBell (CBLL)?

As of Apr 26, 2026, CeriBell (CBLL) is trading at a price of 21.18 USD, with a previous close of 21.06 USD. The stock has fluctuated within a day range of 20.83 USD to 21.31 USD, while its 52-week range spans from 10.85 USD to 24.33 USD.

What Is CeriBell (CBLL) Price Target According to Analysts?

The average 12-month price target for CeriBell is 27.57 USD, with a high estimate of 32 USD and a low estimate of 24 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +30.18% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.